作者: Larry W. Hertel , Theodore S. Lawrence , Emily Chang , Donna S. Shewach , Tina M. Hahn
DOI:
关键词:
摘要: Difluorodeoxycytidine (dFdCyd) is a new antimetabolite with clinical activity in patients with solid tumors but not leukemias. We have studied the metabolism, cytotoxicity, and …